Less-frequent mammographic surveillance showed a similar recurrence-free interval. Evidence Rating Level: 1 (Excellent) Study ...

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...

Biomediq’s breast cancer risk analysis technology is centred around a mammographic texture risk biomarker model that ...